2-methoxyisobutylisonitrile has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, MJ; Kalff, V; Kelly, MJ; Nandurkar, D; Spencer, A; Turlakow, A | 1 |
1 other study(ies) available for 2-methoxyisobutylisonitrile and Multiple Myeloma
| Article | Year |
|---|---|
Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Male; Middle Aged; Multiple Myeloma; Nitriles; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging | 2006 |